Preferred Label : Mhc class II deficiency 1;
Symbol : MHC2D1;
CISMeF acronym : BLS;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Scid, hla class II-negative; Bare lymphocyte syndrome, type II, complementation group a; Severe combined immunodeficiency, hla class II-negative; Bls, type II; Bare lymphocyte syndrome, type II;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the regulatory factor X-associated protein gene (RFXAP, 601861.0001); Caused by mutation in the regulatory factor X, ankyrin repeat-containing gene (RFXANK,
603200.0001); Caused by mutation in the regulatory factor X, 5 gene (RFX5, 601863.0001); Caused by mutation in the MHC class II transactivator gene (MHC2TA, 600005.0001);
Laboratory abnormalities : Reduced CD4 count and proportionally increased CD8 count; Normal number of T and B lymphocytes; Panhypogammaglobulinemia or agammaglobulinemia; Absence of delayed hypersensitivity skin test;
Prefixed ID : #209920;
Origin ID : 209920;
UMLS CUI : C1859534;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
False automatic mappings
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT